Skip to main content
TipRanks
Go Ultimate75% OFF

Standex International (9SI) AI Stock Analysis

0 Followers
DE:9SI

Standex International

(Frankfurt:9SI)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Organic Growth and BacklogSustained organic growth across five consecutive quarters, combined with orders exceeding shipments, indicates broadening demand and improving revenue visibility. A growing backlog can support production planning, capacity utilization, and continued sales expansion over the next several quarters.
Negative Factors
Elevated LeverageLeverage remains materially above historical levels, reducing financial flexibility compared with earlier years. Debt obligations can constrain acquisitions, capital investment, and shareholder returns, while making the business more sensitive to weaker operating conditions or higher financing costs.

Standex International (9SI) vs. iShares MSCI Germany ETF (EWG)

-25%0%25%50%75%100%125%DE:9SI+53.31%EWG+6.38%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 2.97B
Dividend Yield
0.60%
Average Volume (3M)
9
Price to Earnings (P/E)
26.1
Beta (1Y)
0.46
Revenue Growth
3.07%
EPS Growth
104.40%
Country
Germany
Employees
4,100
Sector
Industrials
Sector Strength
63
Industry
Industrial - Machinery

Standex International Business Overview & Revenue Model

Company Description

Standex International Corporation (SXI) operates as a diversified global manufacturer and provider of products and services, catering to commercial and industrial markets across the United States and internationally. The company's operations are stra...

Standex International Earnings Call Summary

Earnings Call Date:Oct 29, 2026(Q1-2027)|% Change Since:-2.61%|Next Earnings Date:Feb 04, 2027
Earnings Call SentimentPositive

The call was strongly positive. Record sales, double-digit organic growth, robust orders, improved margins, accelerated new-product sales, capacity expansion, and a raised fiscal 2027 outlook significantly outweighed the limited challenges, which included the Engraving and Hydraulics decline, lower cash flow, higher corporate costs, capacity-ramp timing, and project timing effects.

Positive Updates

Record Sales and Organic Growth
Fiscal first-quarter sales reached a record $232.6 million, increasing approximately 7% year-on-year, including 12.4% organic growth. This was the fifth consecutive quarter of year-on-year organic growth.

Negative Updates

Engraving and Hydraulics Revenue Decline
Engraving and Hydraulics revenue decreased 14.9% to $40.9 million, reflecting a 15.7% organic decline from softness in the North American automotive market, partially offset by a 0.7% foreign-currency benefit.

Company Guidance

Management expects fiscal second quarter 27 revenue to be “moderately higher” and adjusted operating margin to be “slightly higher” sequentially with “similar adjusted operating margin”; Electronics is expected to have “slightly higher revenue” and “similar adjusted operating margin” sequentially, Aerospace and Defense “significantly higher revenue” and “slightly higher adjusted operating margin,” Scientific “similar to slightly higher revenue” and “similar adjusted operating margin,” and Engraving and Hydraulics “slightly lower revenue and adjusted operating margin.” For fiscal year 27, organic sales are expected to increase “more than $100 million,” total sales to grow “high single digits,” adjusted earnings per share to have “high teens growth,” more than 20 new products to launch, new product sales pro forma for the Federal divestiture to “grow by $27 million $94 million,” and sales into fast growing markets to increase “more than 20%” to “greater than $315 million,” constituting “more than 30%” of total sales; grid sales are expected at “$190 million to $200 million,” capital expenditures at “between $45 million and $55 million,” fiscal second quarter 27 interest expense at “between $7 million to $7.5 million,” and missile-related sales at “closer $20 million this year” and “$50 million to $90 million in the coming years.” Standex remains on track for “greater than $1.1 billion” in sales and “23% adjusted operating margin” by the end of fiscal year 28, also described as “greater than 23% adjusted operating margin.”

Standex International Risk Analysis

Standex International disclosed 27 risk factors in its most recent earnings report. Standex International reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.Ongoing hostilities in the Middle East could disrupt international shipping and adversely affect global energy prices, which could harm our business.Q2, 2026

Standex International Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:9SI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IEXIEX79Outperform$17.40B33.2313.31%1.21%6.93%14.08%
NDSNNDSN73Outperform$18.11B33.1617.59%1.03%7.02%24.24%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
HLIOHLIO61Neutral$1.57B20.118.38%0.94%11.50%134.24%
ESABESAB58Neutral$5.42B35.616.62%0.51%10.97%-38.16%
MIDDMIDD56Neutral$6.25B159.372.18%―-16.65%―

* Industrials Sector Average

Performance Comparison

0%50%100%DE:9SIIEXNDSNHLIOMIDDESABDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:9SI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:9SIStandex International212.0073.7253.31%
IEXIdex Corporation239.9675.1745.61%
NDSNNordson Corporation329.2398.9542.97%
HLIOHelios Technologies Inc48.06-5.04-9.48%
MIDDThe Middleby136.1039.9741.59%
ESABESAB Corporation85.82-25.43-22.86%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.